milacemide






26 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1596690 Effect of milacemide on extracellular and tissue concentrations of dopamine and 5-hydroxytryptamine in rat frontal cortex. Br J Pharmacol 1992 Jan 5
2 1632108 Involvement of FAD-dependent polyamine oxidase in the metabolism of milacemide in the rat. Xenobiotica 1992 Feb 9
3 1634705 Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type. J Am Geriatr Soc 1992 May 1
4 1797336 Effects of the glycine prodrug milacemide (2-N-pentylaminoacetamide) on catecholamine secretion from isolated adrenal medulla chromaffin cells. Br J Pharmacol 1991 Nov 3
5 2043162 Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions? Biochem Pharmacol 1991 Jun 1 3
6 2089081 MAO activity, metabolism and anticonvulsant activity of milacemide in rats and mice. J Neural Transm Suppl 1990 4
7 2128509 Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide? J Neural Transm Suppl 1990 6
8 2196964 Microionophoretic study with milacemide, a glycine precursor, on mammalian central nervous system cells. Br J Pharmacol 1990 May 1
9 2516327 Milacemide, a glycine prodrug, enhances performance of learning tasks in normal and amnestic rodents. Pharmacol Biochem Behav 1989 Dec 1
10 2568664 Brain monoamine oxidase (MAO) B: a unique neurotoxin and neurotransmitter producing enzyme. Prog Neuropsychopharmacol Biol Psychiatry 1989 2
11 2769256 The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B. J Neurochem 1989 Oct 5
12 2784529 Monoamine oxidase inhibitory properties of milacemide in rats. Life Sci 1989 2
13 3138141 The glycine-prodrug, milacemide, increases the seizure threshold due to hyperbaric oxygen; prevention by 1-deprenyl. Eur J Pharmacol 1988 Jun 10 1
14 3346666 Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B. J Neurochem 1988 Apr 7
15 6414480 Effect of milacemide, a glycinamide derivative, on the rat brain gamma-aminobutyric acid system. Biochem Pharmacol 1983 Sep 15 1
16 7646533 Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B. Biochem Pharmacol 1995 Jul 31 6
17 7931256 Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications. J Neural Transm Suppl 1994 1
18 8129740 The interactions of milacemide with monoamine oxidase. Biochem Pharmacol 1994 Feb 11 2
19 8216383 A discontinuous luminometric assay for monoamine oxidase. Biochem Pharmacol 1993 Oct 5 2
20 8474100 Inactivation of monoamine oxidase B by analogues of the anticonvulsant agent milacemide (2-(n-pentylamino)acetamide). J Med Chem 1993 Feb 19 4
21 8485621 Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: milacemide. Br J Pharmacol 1993 Apr 3
22 8512628 Evaluation of multiple doses of milacemide in the treatment of senile dementia of the Alzheimer's type. J Geriatr Psychiatry Neurol 1993 Apr-Jun 2
23 9755023 Milacemide, a glycine pro-drug, inhibits strychnine-allodynia without affecting normal nociception in the rat. Pain 1998 Jul 2
24 10591050 Some peculiar aspects of monoamine oxidase inhibition. Neurobiology (Bp) 1999 2
25 14697904 A screening system of prodrugs selective for MAO-A or MAO-B. Neurotoxicology 2004 Jan 3
26 20504633 Milacemide, the selective substrate and enzyme-activated specific inhibitor of monoamine oxidase B, increases dopamine but not serotonin in caudate nucleus of rhesus monkey. Neurochem Int 1990 3